Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T18:59:21.765Z.
Consensus retrieved: 2026-10-06T16:56:32.222Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T18:59:21.765Z.
Quote observation: 2026-10-06T18:38:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f3fd66fa07f89ff8c2236b8eda0ba832ed38a6b1a46891be7cbf8760d0061f77
FORWARD PE RATIO
N/A
XORTX Therapeutics Inc.
Market Cap
$484571.00
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| XORTX Therapeutics Inc. (XRTX) | $484571.00 | N/A |
| VivoSim Labs, Inc. (VIVS)vs › | $530421.00 | N/A |
| HCW Biologics Inc. (HCWB)vs › | $552749.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $357350.00 | N/A |
| CDT Equity Inc. (CDT)vs › | $663982.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $749648.00 | N/A |
| Ridgetech, Inc. (RDGT)vs › | $834466.00 | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $840882.00 | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
Consensus estimates for this stock are reported in USD, while the share price trades in USD — so per-fiscal-year implied multiples can't be computed honestly here. The analyst estimates table shows the consensus figures with their correct currency label.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
